Medicenna Therapeutics Corp. announced the departure of Jeff Caravella as Chief Business Officer, effective October 26, 2023.
Delayed
Other stock markets
|
5-day change | 1st Jan Change | ||
2.27 CAD | -4.22% | -8.10% | +440.48% |
May. 13 | Medicenna Says ABILITY-1 Abstract Withdrawn by ASCO Program Committee | MT |
May. 13 | Medicenna Brief: Providing Update on its Presentations at the 2024 ASCO Annual Meeting | MT |
EPS Revisions
1st Jan change | Capi. | |
---|---|---|
+440.48% | 125M | |
+42.20% | 50.93B | |
-0.46% | 42.12B | |
+49.62% | 42.05B | |
-7.20% | 29.18B | |
+13.51% | 26.02B | |
-22.13% | 18.9B | |
+7.56% | 13.21B | |
+24.05% | 12.17B | |
+30.19% | 12.16B |
- Stock Market
- Equities
- MDNA Stock
- News Medicenna Therapeutics Corp.
- Medicenna Therapeutics Corp. Announces the Departure of Jeff Caravella as Chief Business Officer